INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,987,142 | -25.7% | 379,100 | -4.2% | 0.48% | -14.4% |
Q2 2023 | $16,142,967 | +3.9% | 395,855 | -5.1% | 0.56% | +9.3% |
Q1 2023 | $15,541,590 | -30.2% | 417,000 | -34.7% | 0.52% | +7.1% |
Q4 2022 | $22,266,798 | -60.2% | 638,200 | -36.1% | 0.48% | -57.6% |
Q3 2022 | $55,910,000 | -4.0% | 999,100 | -11.2% | 1.14% | -15.0% |
Q2 2022 | $58,240,000 | +105.5% | 1,125,194 | +188.5% | 1.34% | +126.6% |
Q1 2022 | $28,347,000 | -15.8% | 390,075 | +55.4% | 0.59% | -20.9% |
Q3 2021 | $33,672,000 | -45.3% | 251,000 | -33.9% | 0.75% | -55.1% |
Q2 2021 | $61,526,000 | +273.3% | 380,000 | +25.4% | 1.66% | +210.8% |
Q4 2020 | $16,483,000 | +87.5% | 303,000 | -27.5% | 0.54% | -5.0% |
Q2 2020 | $8,790,000 | – | 418,178 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |